Home
Medical News
Lastet 10 Medical News
U.S. Food And Drug Administration Approves Pfizer’s INLYTA (axitinib) For Patients With Previously Treated Advanced Renal Cell Carcinoma (RCC)
Pfizer Announces FDA Acceptance Of New Drug Application For Bosutinib For Patients With Previously Treated Ph Chronic Myeloid Leukemia
FDA approves Inlyta to treat patients with a type of advanced kidney cancer
FDA Drug Safety Communication: New risk factor for Progressive Multifocal Leukoencephalopathy (PML) associated with Tysabri (natalizumab)
FDA. New and Generic Drug Approvals - January 27, 2012
FDA. New and Generic Drug Approvals - January 26, 2012
FDA. New and Generic Drug Approvals - January 25, 2012
FDA. New and Generic Drug Approvals - January 24, 2012
FDA. New and Generic Drug Approvals - January 23, 2012
FDA. New and Generic Drug Approvals - January 20, 2012
Dictionary
Browse alphabetically:
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
W
V
Y
Z
Drugs A-Z
Browse alphabetically Medicines Human:
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
Orfan Drugs
Browse alphabetically Supplements:
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
Wiew Veterinary medicines:
All Veterinary medicines
Health articles
Choose category
Herbal Articles
Toxic Substances A-Z Index
Parasitic Diseases
Mendeleev periodic table
Pharmaceutical companies
Medicinal plants list
EU Drugs
Cosmetics
Be eco! Be organic!
List of Vitamins
List of Minerals
Active substances and excipients
Medical Tests. Diagnostics
Health Organizations
Symptoms and signs of disease
List of Diseases
Drug manufacturers
Choose country
UK
Canada
USA
Denmark
Greece
Norway
Poland
Portugal
Germany
France
Japan
Brazil
Sweden
Italy
Spain
China
Argentina
Czech Republic
Hospitals Worldwide
Choose country
Australia
Brazil
Canada
India
Ireland
Israel
Malaysia
Mexico
Netherlands
Nigeria
Saudi Arabia
South Africa
Spain
Switzerland
USA
UK
Search Company
Home
»
Drugs Manufacturers
UK
AFFINITI Research Products
Akita Pharmaceuticals
Advanced Technologies (Cambridge) Ltd (ATC)
Advante Holdings (UK)
A1 Pharmaceuticals Plc
A. Menarini Diagnostics
... more
Canada
Fermentas International Inc
H3 Pharma Inc
Genpharm Inc.
1956 Bourdon
Abbott Laboratories
Altana Pharma Inc
... more
USA
GynoPharma Laboratories
Harber Pharmaceutical Co
Community Bio-Resources, Joplin Missouri
Abbott Laboratories, Ponce, Puerto Rico
Abbott Ambulatory Infusion Systems
Dr. Nordyke Footcare Products
... more
Denmark
Christian Friis & Co.
A/S Vitapharm
Pharmavit
Bioglan DK
Apodan
Abigo
... more
Greece
GALDERMA HELLAS TRADE OF PHARMACEUTICAL PRODUCTS
A. Nikolakopoulos & Co. O.E
Bausch & Lomb Greece
Iliapharm
Chrispa Alpha Pharmaceuticals
Doctum Pharmaceutical S.A. K.T. Giokaris & Co
... more
Norway
Isopharma
Diatec
Farmagon
Alza Pharmaceuticals
Erling & Morten Lind
A-Viral
... more
Poland
Mallinckrodt Polska Sp. z.o.o.
Argon Zaklady Chemiczne
AB Carls-Bergh Amis of Poland
Anpharm
Alfa Wassermann Medagro
Apipol - Farma Sp. z o.o.
... more
Portugal
Bios-Alfamede - Produtos Quimicos e Farmaceuticos
BD (Becton Dickinson) SA (Portugal)
Allergan S.A. Escritorio de Representa?ao Portugal
Unifa - Uniao Fabril Farmaceutica, S.A.
Amgen Biofarmaceutica
Ciba Vision Portugal
... more
Germany
Marien-Pharma
Bilgast Arzneimittel Vertriebs
Bahnhofstr. 23 Gebr. Waaning-Tilly Fabrik Pharm.
Amersham Buchler GmbH & Co. KG
Agilpharma Dr. Rudolf Lang
Alsitan Naturheilmittel
... more
France
Apivar
Aspir-Aspivenin
Hepatrol Sarl Laboratoire
Laboratoire Ornis
Laboratoires Gani - division de Ganex-France
Albacor
... more
Japan
AstraZeneca K.K. (Tokyo Regional Office)
Sawai Seiyaku
B.L.J. Company
Amersham K.K
Takeshima Pharm
Allergan K.K
... more
Brazil
Akzo nobel Ltda. - divisao Organon de Brasil
CIF. Cia. Industrial Farmaceutica
Biolab Farmaceutica
Carlo Erba S.A.
Auad quimica. Ltda.
Casa Granado Laboratorios. Farmacias e Drogarias S/A
... more
Sweden
Active Health Pharma
Beiersdorf
Biolac
Anatomica
Aventis Behring
ALK Sverige
... more
Italy
Bayropharm Italiana S.r.L
Difer - Industrie Farmaceutiche Triestine S.r.L
Agips Farmaceutical S.r.L
Agatone C. Export S.r.L
Sifra Omeopatici
A. Costantino & C.
... more
Spain
Biogen Farmaceutica
Gonmisol S.A.
Laboratorios Korhispana
BIAL-Industrial Farmaceutica S.A.
3M Espa?a S.A. (Farmaceutica)
ALLERGAN
... more
China
Hangzhou Sanofi-Synthelabo Minsheng Pharmaceutical Co
GALDERMA INTERNATIONAL - Beijing Representative Office
Lek Pharmaceuticals d.d.,
Merck Beijing Representative Office
Beijing Prorepharm Co.,
Boehringer Ingelheim Shanghai Pharmaceuticals Co., Ltd.
... more
Argentina
Asofarma
IPI ASAC ARGENTINA,
Alet S.A.I.C.I.y E.
Bonru Perel, Lab. Derm.
Armstrong S.A.C.I.F.
Allergan-Loa S.A.I.C.y F.
... more
Czech Republic
Deleeuw health spol.s.r.o
Biofyzikalni Ustav Csav
Berlin-Chemie AG
Allergan Eco-Med-Poll PragueAllergan Eco-Med-Poll Prague
Germed
Cadila Healthcare
... more
General Search
Latest News
U.S. Food And Drug Administration Approves Pfizer’s INLYTA (axitinib) For Patients With Previously Treated Advanced Renal Cell Carcinoma (RCC)
Pfizer Announces FDA Acceptance Of New Drug Application For Bosutinib For Patients With Previously Treated Ph Chronic Myeloid Leukemia
FDA approves Inlyta to treat patients with a type of advanced kidney cancer
FDA Drug Safety Communication: New risk factor for Progressive Multifocal Leukoencephalopathy (PML) associated with Tysabri (natalizumab)
FDA. New and Generic Drug Approvals - January 27, 2012
Latest Drugs
Efavirenz Teva
Desloratadine Actavis
Repaglinide Accord
Emselex
Hepsera
Zulvac 1 Ovis
Zulvac 1 Bovis
Levetiracetam Sun
Inovelon
Olanzapine Glenmark Europe
Last medical tags:
Torisel
,
temsirolimus
,
Inlyta
,
chronic myeloid leukemia
,
bosutinib
,
Inlyta
,
renal cell carcinoma
,
kidney cancer
,
myelin
,
Tysabri
,
natalizumab
,
brain infection
,
progressive multifocal leukoencephalopathy
,
FDA
,
New drugs approval 2012
,
drugs approved by FDA
,
FDA
,
New drugs approval 2012
,
drugs approved by FDA
,
FDA
,
New drugs approval 2012
,
drugs approved by FDA
,
FDA
,
New drugs approval 2012
,
drugs approved by FDA
,
FDA
,
New drugs approval 2012
,
drugs approved by FDA
,
FDA
,
New drugs approval 2012
,
drugs approved by FDA
,
FDA
,
New drugs approval 2012
,
drugs approved by FDA
,
FDA
,
New drugs approval 2012
,
drugs approved by FDA
,
thoracic aortic transection
,
endovascular graft
,
methotrexate
,
Voraxaze
,
cancer chemotherapy drug
,
glucarpidase
,
Adcetris
,
bleomycin
,
multifocal leukoencephalopathy
,
CardioGen-82
,
radiation
,
FDA
,
New drugs approval 2012
,
drugs approved by FDA
,
FDA
,
New drugs approval 2012
,
drugs approved by FDA
,
FDA
,
New drugs approval 2012
,
drugs approved by FDA
,
raltegravir
,
Isentress
,
antiretroviral medicines
,
Theravance
,
Relovair
,
asthma
,
fluticasone
,
bronchitis
,
neuromuscular disease
,
SMA
,
muscle atrophy
,
Resolor
,
prokinetic
,
prucalopride
,
ADHD
,
psychiatric behavioural disorder
,
Venvanse
,
lisdexamfetamine dimesylate
,
type 2 diabetes mellitus
,
Actoplus Met XR
,
pioglitazone
,
Mylan
,
Eprosartan Mesylate Tablets
,
Teveten
,
antimicrobials
,
cephapirin
,
cephalosporin
,
teriflunomide
,
Rebif
,
alanine aminotransferase levels
,
flu-like symptoms
,
multiple sclerosis
,
electrical pulses
,
implantable pulse generator
,
Precision Plus Spinal Cord Stimulator
,
genetic blood clotting disorder
,
hemophilia A
,
Advate
,
bleeding episodes
,
heart failure
,
heart transplantation
,
Pediatric Medical Device Safety
,
pulsatile cardiac assist device
,
selective serotonin reuptake inhibitor
,
SSRI
,
pulmonary hypertension
,
» All tags
Sitemap